GENTAUR Contact Gentaur

Up
AngioKit protocols

GENTAUR Survey

GENTAUR EUROPE

+32 1658 9045
+32 1650 9045

BELGIUM

tel +32 2 732 5688
fax +32 2 732 4414
info@gentaur.com
Av. de l' Armée 68
B-1040 Brussels

France

tel 01 43 25 01 50
fax 01 43 25 01 60
9, rue Lagrange
75005 Paris

Italy

tel 02 36 00 65 93
fax 02 36 00 65 94
20135 Milano

Germany

tel +32 16 58 90 45
fax +32 16 50 90 45
Forckenbeckstraße 6
D-52074 Aachen

Japan

tel +81 78 386 0860
fax +81 78 306 0296
Minaatojimaminami-manchi
Chuo-ku, Kobe
065-0047


Publications citing use of the TCS human cell angiogenesis model. Update October 2004

 1.      Grohmann, M et al, (1999)

‘Nitric oxide released via VEGFR-1 suppresses VEGFR-2 mediated endothelial cell growth and regulates angiogenesis’

J. Reprod. Fertil. (Abs Series 24) No 48

 2.      Brooks, T.D. et al, (1999)

‘Antibodies to PAI-1 suppress angiogenesis in vitro

Clin. Exp. Metastasis 17 (9); 112  

3.      Bishop, E.T. et al, (2000)

‘An in vitro model of angiogenesis: Basic features

Angiogenesis 3; (4); 335-344 

4.      Bryant,  et al , (2000)

‘Tissue repair with a therapeutic transcription factor’

Human Gene Therapy 11; 2143-2158

 5.      Donovan et al, (2001)

‘Comparison of three in vitro human ‘angiogenesis’ assays with capillaries formed in vivo

Angiogenesis 4; 113-121

 

6.      Frandsen, T. et al,  Clin. Cancer Res. 7; Suppl. (2001)

 

7.      Bussolati, B. et al, (2001)

‘Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide’

Am. J. Path. 159; 993-1008

 8.      Houston, P. et al, (2001)

‘The transcriptional co-repressor NAB2 blocks Egr-1-mediated growth factor activation and angiogenesis’

Biochem. Biophys. Res. Commun. 283; 480-486

 9.      Murphy, J.E. & Fitzgerald, D.J., (2001)

‘Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor’.

FASEB J. 15; 1667-1

 10.  Jia, H. et al, (2001)

‘Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF’

Biochem. Biophys. Res. Commun. 283; 164-173

 

11.  Ohno-Matsui, K. et al, (2001)

'Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF'

J. Cell. Physiol. 189; 323-333

  

12.  Terai, Y. et al, (2001)

'Vascular smooth muscle cell growth promoting factor / F-spondin inhibits angiogenesis via the blockade of integrin aVb3 on vascular endothelial cells.

J. Cell. Physiol. 188; 394-402 

13.  Harmey, J.H. et al, (2002)

'Lipoylsaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumour invasion'

Int. J. Cancer 101; 415-422  

14.  Iba, O. et al, (2002)

"Angiogenesis by implantation of peripheral blood mononuclear cells into ischaemic limbs"

Circulation 106: 2019 

15.  Rossig, L., et al, (2002)

"Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation & angiogenesis"

Circulation Research 91, 837-851 

16.  Gliki, G. et al, (2002)

‘Vascular endothelial growth factor induces protein kinase c (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3’-kinase-mediated PKCd phosphorylation: Role of PKC in angiogenesis’

Cell Biology International 26; 751-759  

17.  Brooks, T. et al,  Proc. AACR 43; 137 (2002) 

18.  Drinkwater, S.L., et al, (2002)

‘Effect of venous ulcer exudates on angiogenesis in vitro’

Brit. J. Surg. 89; 709-713 

19.  Urbich, C. et al. (2002)

'Dephosphorylation of endothelial nitric oxide synthase contributes to the

anti-angiogeneic effects of endostatin'.

FASEB J. express article 10.1096/fj.01-0637fje. 

20.  Urbich, C. et al. (2002)

'Double-Edged Role of Statins in Angiogenesis Signalling'

Circulation Research. 90: 737-744. 

21.  Osugi, T. et al (2002)

'Cardiac-specific activation of Signal Transducer and Activator of Transcription-3 promotes vascular formation in the heart'

J. Biol. Chem. 227; 6676-6681 

22.  Kronenwett, R. et al, (2002)

'Inhibition of angiogenesis in vitro by aV integrin-directed antisense oligonucleotides'.

Cancer Gene Therapy 9; 587-596 

23.  Dredge, K. et al (2002)

'Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects'.

Brit. J. Cancer 87; 1166-1172 

24.   Urbich et al (2002)

'CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species'

Circulation, 106; 981-986 

25.  Svensson, L.A. et al (2002)

'The cytolethal distending toxin of Haemophilus ducreyi inhibits endothelial cell proliferation'

Infection & Immunity 70; 2665-2669 

26.  Sengupta, S. et al (2003)

'Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms'

Brit. J. Pharmacol. In Press 

27.  Oshima, Y. et al, (2003)

'Expression and localisation of tenomodulin, a transmembrane type chondomodulin-I-related angiogenesis inhibitor, in mouse eyes'.

Invest. Ophthalmol. Vis. Sci. 44; 1814-1823 

28.  Igagarishi, T. et al (2003)

'Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularisation in a murine proliferative retinopathy model'.

Gene Therapy 10; 219-226 

29.  Shalhoub, J. et al, (2003)

'Anti-angiogenic activity of heparins and antithrombin

J. Thromb. Haemostasis 1 Suppl July, P0846  

30.  Burns, P.A. & Wilson, D.J., (2003)

'Angiogenesis mediated by metabolites is dependent on VEGF'

Angiogenesis 6; 23-77 

31.  Duval, H. et al, (2003)

'New insights into the function and regulation of endothelial cell apoptosis'

Angiogenesis  6; 171-183 

32.  Cai, J. et al, (2003)

'Activation of VEGF-R1 sustains angiogenesis and Bcl-2 expression via the PI3-kinase pathway in endothelial cells'

Diabetes 52; 2951-2968 

33.  Patel et al, (2004)

'Enhanced angiogenesis following allogeneic blood transfusion'

Clin. Lab. Haematol. 26; 129-134  

34.  Zhang, W. et al, (2004)

'Effects of insulin-like growth factor-binding proteins 1 through 5 on in vitro angiogenesis assay'

Proc. AACR 45; 4341 March 2004  

35.  Newman, S. et al,  (2004)

'Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates'

Int. J. Cancer 109; 533-540 

36.  Campioni, D. et al, (2004)

'In vitro evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach'.

Leuk. Res. 28; 9-17   

37.  Kumar, S. et al, (2004)

'Bone marrow angiogenic ability and expression of angiogenic cytokines in melamoma: Evidence favouring loss of marrow angiogenesis inhibitory activity with disease progression'

Blood 104: 1159-1165  

38.  Print, C. et al, (2004)

'Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome'

Hum. Reprod. 19; 2356-2366 

 

TCS AngioKit:  CD31 stained tubule formation


 

Home ] Up ] AngioKit protocols ]

Send mail to webmaster@gentaur.com with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified: 11/21/08